[19] [20] En el cerebro, la activacin del receptor de GLP-1 se ha relacionado con efectos neurotrficos que incluyen neurognesis, [21] [22] y efectos neuroprotectores que incluyen sealizacin necrtica reducida [23] y apopttica [24] [23] muerte celular, [25] [26] y disfunciones
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that acts on both pathways
Its effects on the HGF/c-Met pathway, while beneficial for neural repair, require careful consideration regarding long-term use
Recently, the drug has become a popular choice for the management of obesity, and even athletes have been turning to it to help them lose weight
New formulations, regulatory evaluations, and continuous clinical trials will probably shape future peptide treatment